VERICEL CORPORATION

VCEL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $89.0K $182.0K
Cost of Revenue $34.0K $112.0K
Gross Profit $55.0K $70.0K
Gross Margin 61.8% 38.5%
Operating Expenses
Research & Development $12.7M $11.3M
SG&A Expense $5.2M $5.0M
Operating Income $-17.8M $-16.2M
Operating Margin -20,004.5% -8,884.1%
Interest Expense $40.0K $73.0K
Pretax Income $-14.6M
Income Tax Expense
Net Income $-14.6M $-16.1M
Net Margin -16,357.3% -8,824.7%
EPS (Basic) $-0.59 $-0.90
EPS (Diluted) $-0.59 $-0.90
Shares Outstanding (Basic) 24.7M 17.9M
Shares Outstanding (Diluted) 24.7M 17.9M
Dividends Per Share
← Newer Page 3 of 3 Older →